reference/8193426

Predicate	Object
contentType	Journal Article
endingPage	500
issn	2150-0878
issueIdentifier	5
pageRange	494-500
publicationName	Journal of the Advanced Practitioner in Oncology
startingPage	494
bibliographicCitation	L. Merchant, PharmD S, Culos, PharmD, BCOP K, Wyatt, PharmD, CSP H. Ivosidenib: IDH1 Inhibitor for the Treatment of Acute Myeloid Leukemia. JADPRO. 2019 Jul 01;10(5). doi: 10.6004/jadpro.2019.10.5.7.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c29e1c925f272d3316cdb8f0039a189b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0564aaf4c45a7be2d3a276fab517ac9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07cd83459d2ab784ee115cbd8c422303
date	2019-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.6004/jadpro.2019.10.5.7 https://pubmed.ncbi.nlm.nih.gov/PMC7779565 https://pubmed.ncbi.nlm.nih.gov/33457062
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/41396 https://portal.issn.org/resource/ISSN/2150-0878
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Ivosidenib: IDH1 Inhibitor for the Treatment of Acute Myeloid Leukemia
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71657455

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3417

Total number of triples: 25.